[ad_1]
Did you miss a session from the Way forward for Work Summit? Head over to our Way forward for Work Summit on-demand library to stream.
Verana Well being, a digital well being firm that leverages huge information insights to reinforce medical analysis, has raised $150 million in a sequence E spherical of funding.
The San Francisco-based firm has shaped unique information partnerships with quite a few notable medical associations, together with the American Academy of Ophthalmology, the American Academy of Neurology, and the American Urological Affiliation, to mixture and analyze anonymized affected person information and expedite the event of latest medicine. It additionally claims to work with quite a few multinational pharmaceutical corporations and “rising biotechnology and biopharmaceutical corporations.”
AI meets healthcare
Verana Well being has two core merchandise — the VeraQ platform, which is pitched as a well being information engine that connects disparate, unfiltered healthcare information; and Qdata, that are information units derived from VeraQ for ailments together with ophthalmology, neurology, and urology. The Verana Well being platform makes use of pure language processing (NLP) and machine studying to “protect the integrity of the unique medical context” of a healthcare supplier’s notes and inputs — basically, making sense of unstructured textual content information in digital well being information (EHRs).
Based initially as DigiSight Applied sciences again in 2008, the corporate rebranded as Verana Well being again in 2018 alongside a $30 million funding led by Alphabet’s enterprise capital arm GV. With a contemporary $150 million within the financial institution, Verana Well being stated that it plans to double down on its product growth and “increase its information footprint” via constructing extra partnership with the medical and healthcare fraternity.
For its sequence E spherical, Verana Well being has attracted a slew of big-name strategic and institutional traders, together with lead backers Johnson & Johnson Innovation and Novo Development, in addition to GV, Casdin Capital, Brook Byers, the Merck World Well being Innovation Fund, THVC, and Breyer Capital.
VentureBeat
VentureBeat’s mission is to be a digital city sq. for technical decision-makers to achieve information about transformative expertise and transact.
Our website delivers important data on information applied sciences and methods to information you as you lead your organizations. We invite you to change into a member of our group, to entry:
- up-to-date data on the themes of curiosity to you
- our newsletters
- gated thought-leader content material and discounted entry to our prized occasions, corresponding to Remodel 2021: Be taught Extra
- networking options, and extra
[ad_2]
